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Abstract
Background: Mediastinitis is a rare, but serious complication of cardiac surgery. It has a significant
socioeconomic impact and high morbidity. The purpose of this study was to determine pre-, intra-
, and postoperative predictors of mediastinitis.
Methods and results: In 1700 consecutive patients, who underwent cardiac surgery in 2001, 49
variables were retrospectively assessed. Forty-five patients (2.65%, 95% CI [1.88; 3.41]) developed
postoperative mediastinitis. None of these patients died during their hospitalization. Multivariate
analysis identified three of the 49 variables as highly significant independent predictors for the
development of mediastinitis: obesity (OR 1.03, 95% CI [1.01; 1.04] p = 0.001), chronic obstructive
pulmonary disease (OR 3.30, 95% CI [1.58; 6.88], p = 0.001), and bilateral grafting of the internal
mammary artery (OR 3.18, 95% CI [1.20; 8.43] p = 0.02). The model is reliable in terms of its
g o o d n e s s  o f  f i t ,  i t  a l s o  d i s c r i m i n a t e s  w e l l .  A d ditionally, univariate analysis identified diabetes
mellitus, CCS class and the number of intraoperatively transfused units of fresh frozen plasma as
variables with a significant impact.
Conclusion: The present study suggests that bilateral IMA grafting, chronic obstructive pulmonary
disease and obesity are important predictors of mediastinitis.
Background
As a severe complication of cardiac surgery, mediastinitis
continues to be associated with tremendous morbidity
and cost [1]. The exact pathogenetic mechanisms underly-
ing postoperative mediastinitis remain unknown; multi-
ple factors might play a role. Some authors favor the
intraoperative contamination [2], whereas other studies
demonstrated that endogenous bacteria might be patho-
genetically involved [3,4] because preoperative intranasal
antibiotic treatment significantly reduced the incidence of
mediastinitis.
Several studies published during the last ten years
reported an incidence of 0.4 to 5% [5,6] and in-hospital
mortalities between 14 and 23%, even when mediastinitis
was correctly treated [7-9]. Postoperative mediastinitis is
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also associated with high long-term mortality [10,11].
Braxton et al. compared in a 4-year follow-up study the
survival rates of patients with and without mediastinitis
after cardiac operations. Eighty nine percent of patients
survived in the non-mediastinitis group compared to 65%
in the mediastinitis group after four years [10].
In 1963 Shumacker and Mandelbaum first described a
method for the treatment of postoperative mediastinitis
[12] which still forms the basis for current therapeutic
approaches in some centers [13]. Their approach included
early surgical debridement, insertion of a drainage system
with continuous irrigation with antibiotic solution and
primary wound closure.
Modern management of mediastinitis with early aggres-
sive debridement followed by delayed wound closure has
been reported to reduce early mortality to less than 20%.
The vacuum-assisted closure (VAC) was introduced in
1997 [14] and combines the advantages of both open and
closed treatment. Besides an improved local perfusion
and oxygenation, the quantitative bacterial flora is rapidly
reduced and the formation of scar tissue is stimulated
[15,16]. Intermittent suction additionally may promote
wound healing by local reactive hyperemia if suction
stops [17]. Several studies showed the benefits of a VAC
therapy in terms of shorter hospitalizations, earlier sec-
ondary wound closure and a lower mortality compared to
a conventional therapy [18-20]. However, evidence-based
guidelines for the treatment of postoperative mediastinitis
have not been established and published yet.
In this study, we evaluated pre-, intra-, und postoperative
risk factors for mediastinitis and compared the results
with a previous report from our department [21]. This
report analysed 112 mediastinitis patients from 1988 to
1999. There were two major reasons for a new mediastin-
itis study from our department. First, we wanted to know
how several surgical modifications at the end of 1990s in
our clinic (e.g. more frequent IMA use, sternal closure
with wires instead of sutures) influenced the prevalence of
postoperative mediastinitis. Second, we wanted to exam-
ine if the increased incidence of multiple comorbidities
among our patients during the recent decade (e.g.
increased age, more obese patients) may lead to an
increase in mediastinitis after cardiac surgery.
Material, methods and statistics
Patients
The study group consisted of 1700 patients who under-
went cardiac surgery with or without extracorporeal circu-
lation. Patients were recruited from the Department of
Cardiothoracic Surgery at the University of Halle-Witten-
berg and an associated private heartcenter. Patients under-
going sole CABG, sole valve replacement/repair, or
combined CABG/valve procedures were included in the
analysis.
The surgical procedures among our study population were
as follows: sole CABG (n = 1438), sole valve procedure (n
= 155), combination of CABG and valve procedure (n =
89) and other procedures, e.g. ASD closure, (n = 18). IMA
harvesting was performed with a pedicle in 85% (n =
1029) and 15% in a skeletonized way (n = 182). The pro-
phylactic antibiotic regimen in both centers included the
intravenous administration of 2 g Cefotiam one hour pre-
operatively and six hours postoperatively. Cefotiam was
usually continued in all patients with valve procedures (2
g iv tid) until all chest tubes and the central venous cathe-
ter were removed.
Data collection and definition of variables
Data were retrospectively collected from patient records
and entered into an Excel spreadsheet. For most variables,
data were missing in fewer than 0.5% of patients.
Where appropriate, variables such as duration of cardiop-
ulmonary bypass and duration of artificial ventilation
were analyzed as continuous parameters. All other varia-
bles were analyzed as categorical variables. All patients in
the mediastinitis group had purulent deep sternal wound
infections requiring extensive debridement and drainage
as well as bacteriological analyses. Superficial wound
infections sparing the sternum and not requiring exten-
sive debridement and drainage were not classified as
mediastinitis. Microbiological assessment of intraopera-
tive wound swabs was performed at the Institute of Medi-
cal Microbiology of the University of Halle or in the
Laboratory Dr. Reising-Ackermann in Leipzig, Germany.
Where appropriate, we used the EuroSCORE-criteria to
define the variables; e.g. renal failure was considered to be
present when serum creatinine levels exceeded 200 μmol/
l. The term "diabetes" was used for all patients with diabe-
tes, insulin dependent and non-dependent. Chronic
obstructive pulmonary disease refers to disease with long-
term bronchodilator or steroid therapy.
Mediastinitis treatment
Patients with suspected and/or manifest mediastinitis
underwent aggressive surgical exploration with debride-
ment of infected soft tissue and bone using a rongeur and
removal of all sternal wires. Two sets of wound swabbings
were sent for culture. The wound was then irrigated with
antibiotic solution. Nine patients received initial rewiring
of the sternum by the method described by Robiscek [22]
and insertion of a drainage system followed by bilateral
pectoralis muscle mobilization to cover the sternum. Sub-
cutaneous tissue and skin were closed with single sutures.Journal of Cardiothoracic Surgery 2007, 2:23 http://www.cardiothoracicsurgery.org/content/2/1/23
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The wound was irrigated continuously with antiseptic
solution (0,5% povidone-iodine; 4 liters per 24 hours) for
at least three days followed by a continuous saline wash
(4 liters per 24 hours) for 72 hours. Swabbings from the
saline wash were taken every 24 hours and if they were
sterile, the catheters were removed stepwise. None of the
patients underwent a reoperation.
However, the majority of patients received a vacuum-
assisted closure (100 mm Hg suction) after aggressive
debridement to expedite the healing process. The foams
were changed every third day with concomitant wound
swabbings. After sufficient healing, the wounds were
either closed with sternal rewiring and muscle flap recon-
struction (n = 30) or, in case of loss of sternal bone, with
an omentum plastic (n = 6) and secondary wound heal-
ing.
The results from the wound swabbings dictated the anti-
biotic regimen. Patients with suspected and/or manifest
mediastinitis initially received Piperacilline 2 g iv tid in
combination with a β-lactamase inhibitor and, if neces-
sary, the regimen was changed according to the resisto-
grammes.
Statistics
Statistical evaluation was performed using SPSS 11 for
Windows [23]. After testing for (non)-normality with the
Shapiro-Wilk test, continuous parameters were analyzed
with non-parametric tests for independent groups. Cate-
gorical variables were analyzed with the Chi-Square-test
or, where appropriate, with Fisher's exact test. A p-value <
0.05 was considered significant. Predictors of mediastini-
tis were analyzed with multivariate logistic regression
(stepwise forward algorithm); goodness of fit was tested
with the Hosmer-Lemeshow test. A Receiver Operating
Characteristic analysis (ROC) with the data from the
logistic regression was used to determine if the model suf-
ficiently discriminates between patients with and without
mediastinitis.
Data are shown either as mean ± standard deviation or
median with range.
Results
Incidence, hospital stay and in-hospital mortality
Forty-five of 1700 patients operated on in 2001 (2.65%)
developed postoperative mediastinitis. Twelve patients
(27%) had already been transferred to the rehabilitation
facilities and were readmitted for the treatment of postop-
erative mediastinitis. The mean postoperative length of
stay was 43 ± 35 days (95% CI: 32; 54) for the mediastin-
itis group compared to 19 ± 17 days (95% CI: 18; 20) for
patients without mediastinitis (p < 0.001). None of the 45
patients in the mediastinitis group died, whereas 73
patients in the non-mediastinitis group (4.4%) expired
during their hospital stay.
Preoperative risk factors analysis
By univariate analysis, the following six variables were
associated with an increased risk of mediastinitis (p <
0.05): body mass (respectively body mass index), chronic
obstructive pulmonary disease (COPD), CCS class, bilat-
eral IMA use and diabetes mellitus (Table 1).
Perioperative risk factor analysis
We examined the following perioperative parameters:
urgency (elective, urgent, emergency), use of intraaortic
balloon counterpulsation, operative time, duration of car-
diopulmonary bypass, catecholamines dose, transfusion
of red cell or platelet concentrates, number of transfused
units of fresh frozen plasma, and lowest intraoperative
body temperature. Only the number of intraoperatively
transfused units of fresh frozen plasma proved to be a sta-
tistically significant risk factor for the development of
mediastinitis (598 ± 361 ml versus 1600 ± 0 ml). This
finding is based on one single patient, however.
Postoperative risk factor analysis
Postoperative variables included postoperative bleeding,
body temperature, catecholamine dose, cardiac enzyme
levels (creatinine kinase, troponin I), and duration of arti-
ficial ventilation. None of these variables showed a signif-
icant difference between the groups with versus without
mediastinitis.
Multivariate logistic regression model
The significant variables except FFP transfusion and some
almost significant variables (p < 0.1) from the univariate
analysis (peripheral arterial disease, preoperative hemo-
globin level, duration of operation, duration of bypass,
postoperative intraaortic balloon counterpulsation) were
included in the multivariate logistic regression analysis.
Three independent predictors of mediastinitis were iden-
tified (Table 2).
Goodness of fit was tested with the Hosmer-Lemeshow
test (third step: p = 0.59, χ2 = 6.47). The generated model
showed a useful goodness of fit. To discriminate between
patients with and without mediastinitis, a ROC analysis
was performed with the data from the logistic regression
(Figure 1).
Bacteriology
S. aureus was isolated from 16 wounds (32%) and S. epi-
dermidis from 12 wounds (24%). From the remaining
wounds, several other bacterial species could be isolated,
including E. coli, Klebsiella spp., Pseudomonas aerugi-
nosa, Enterococcus faecalis, Serratia marcescens, and
Corynebacterium species. In one mediastinitis patient, noJournal of Cardiothoracic Surgery 2007, 2:23 http://www.cardiothoracicsurgery.org/content/2/1/23
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Table 1: Prevalence of preoperative risk factors
Variable Mediastinitis (n) Σ (n) p
No Yes
Age (years) 64.1 ± 10.2 66.5 ± 8.73 1700 0.71
Gender
Male 1175 37 1212 n.s.
Female 479 8 487
Body mass index (kg/m2) 28.0 29.8 1700 0.008
Hypertension
No 273 7 280 n.s.
Yes 1381 38 1419
Diabetes mellitus
No 1086 23 1109 0.05
Yes 568 22 590
Active Smoking
No 858 15 873 n.s.
Yes 295 11 306
COPD
No 1507 35 1542 0.006
Yes 147 10 157
Peripheral vascular disease
No 1465 39 1504 n.s.
Yes, untreated 132 3 135
Yes, treated 56 3 59
Ejection fraction (% ± SD) 59.6 ± 15.8 58.7 ± 15.0 1700 n.s.
Previous cardiac surgery
No 1607 45 1652 n.s.
Yes 47 0 47
NYHA class
I 113 3 116 n.s.
II 882 19 901
III 566 20 586
IV 55 2 57
CCS class
I 100 0 100 0.02
II 725 15 740
III 686 23 709
IV 104 7 111
Renal insufficiency
No 1318 30 1348 n.s.
Yes, compensated 309 14 323
Yes, dialysis 16 1 17
Status post renal transplantation 4 0 4
Hemoglobin (mmol/l ± SD) 8.6 ± 1.1 8.4 ± 1.2 1697 n.s.
Creatinine (μmol/l ± SD) 96.7 ± 64.9 109.1 ± 58.7 1690 n.s.
Blood urea nitrogen (mmol/l ± SD) 6.8 ± 3.2 7.5 ± 4.4 1672 n.s.
Surgical technique
cardiopulmonary bypass 1276 32 1308 n.s.
OPCAB 276 9 285
PACAB 18 0 18
MIDCAB 84 4 88
Number of bypasses (n ± SD) 2.6 ± 1.2 2.7 ± 1.1 1699 n.s.
Use of LIMA
No 479 9 488 n.s.
Yes 1175 36 1211
Bilateral IMA use
No 1587 40 0.02
Yes 67 5Journal of Cardiothoracic Surgery 2007, 2:23 http://www.cardiothoracicsurgery.org/content/2/1/23
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bacteria could be initially isolated, but S. aureus was
found in a swabbing obtained three days later during a
foam exchange for VAC therapy. In six patients, we identi-
fied a mixed mediastinal flora.
Discussion
Since it was first introduced by Julien et al. in 1957,
median sternotomy has been established as the standard
approach for open heart surgery [24]. Mediastinitis con-
tinues to be a major complication of cardiac surgery and
is associated with tremendous morbidity and cost. The
incidence of postoperative mediastinitis varied between
0.5 and 5% in several studies. Our reported incidence of
2.65% is in agreement with recently published results
[21,25]. Long-term mortality has been extensively investi-
gated in several studies. Ridderstolpe et al. showed a 30-
day mortality of 1%, and a mortality of 7.2% after one
year of follow-up.
The economic impact of postoperative mediastinitis has
also been evaluated in several studies, most of which were
conducted in the United States. Very few studies apply to
German hospitals. Our data show a significantly pro-
longed hospital stay. On the average, patients with medi-
astinitis were hospitalized 24 days longer than patients
without this complication. Hollenbeak et al. reported that
the mediastinitis treatment required 20 additional hospi-
tal days [1]. Our data come quite close to the data from
this study.
During the recent ten years, several studies evaluated risk
factors for postoperative mediastinitis [2,7-9,21,25-40]. It
is of note, however, that low patient numbers and multi-
ple statistical tests can lead to false positive results [41].
While the above mentioned studies did identify numer-
ous predisposing factors, they also led to some contradic-
tions, primarily because mediastinitis, deep sternal
wound infection, and sternal instability were defined dif-
ferently from one study to the next. This is compounded
by geographical differences, different study durations and
varying endpoints.
The most frequently mentioned risk factor is obesity. Our
data also show that the risk for mediastinitis increases by
three percent per additional kilogram body mass per
square meter body surface. Why obesity presents a risk fac-
tor was discussed by Milano et al. and Bitkover et al.
[2,41]. The etiology relates to increased postoperative
mechanical loads, facilitated bacterial contamination,
and failure to adjust antibiotic doses to body mass, an
error that leads to inappropriately low tissue antibiotic
concentrations. Additionally, the bradytrophic properties
of fatty tissue contribute to poor wound healing.
Our data also link bilateral IMA use to an increased risk of
postoperative mediastinitis. This is explained by reduced
sternal perfusion after IMA dissection [34]. One animal
study demonstrated that sternal blood flow was decreased
by 90% after bilateral IMA dissection [42]. Carrier et al.
showed that after bilateral IMA dissection, sternal per-
fusion was reduced by 24 ± 6%. Four weeks postopera-
tively, sternal blood flow was still reduced by 2 ± 2% [43].
Low sternal perfusion may lead to tissue necrosis and can
impair wound healing. This is contradicted by several
studies which demonstrated that bilateral IMA use is not
associated with increased rates of postoperative medias-
tinitis [27,44]. Both authors skeletonize the IMA instead
of dissecting it with a pedicle. Even diabetic patients ben-
efit from skeletonized IMA dissection [45,46]. IMA har-
vesting might indeed contribute to the development of
Total arterial revascularization
No 1276 31 1307 n.s.
Yes 378 14 392
Prevalence of preoperative risk factor among the study population. Data are shown either as absolute numbers or as mean ± SD. Besides several 
demographic data, there are also variables describing clinical conditions and surgical technique.
Table 1: Prevalence of preoperative risk factors (Continued)
Table 2: Final multivariate model
Variable B SD Wald P (Wald) Odds Ratio 95% CI
Body mass index 0.03 0.009 10.51 0.001 1.03 1.012 1.049
COPD 1.19 0.37 10.17 0.001 3.30 1.58 6.88
BIMA use 1.15 0.49 5.44 0.020 3.18 1.20 8.43
Constant -6.33 0.82 59.17 < 0.0001 0.002
Final multivariate model. B denotes the coefficient derived from computed stepwise logistic regression and the Odds ratio is statistically ecoefficient 
and describes the probability of having a mediastinitis in the presence of a risk factor. The Wald test was obtained by comparing the maximum 
likelihood estimate of the slope parameter to an estimate of its standard error. SD is the standard error of B and the 95% CI refers to the Odds 
ratio.Journal of Cardiothoracic Surgery 2007, 2:23 http://www.cardiothoracicsurgery.org/content/2/1/23
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postoperative mediastinitis in our study because the
majority of this conduit was dissected as a pedicle.
The third independent predisposing factor in our study
population was COPD, which was associated with a more
than threefold increased risk of postoperative mediastini-
tis, possibly as a result of frequent coughing, which might
contribute to wound dehiscence and thereby facilitate
bacterial migration [38]. Patients with COPD also experi-
ence more frequent respiratory infections and prolonged
weaning from artificial ventilation [33,40,47].
We also compared the identified risk factors with data
from a recent report from our department [21]. The only
risk factor common to both studies was obesity, whereas
low cardiac output, smoking, age, postoperative respira-
tory failure and the type of sternal closure were not related
to the risk of postoperative mediastinitis.
It is noteworthy that we found no difference in the preva-
lence of mediastinitis between operations with or without
extracorporeal circulation (Off-pump).
Our data also demonstrate the need for preventive meas-
ures. Weight reduction (in case of elective surgery), weight
adapted perioperative antibiotic treatment and a strict
antidiabetic regimen proved to be effective procedures
[17,22,24].
Conclusion
We conclude from our study that bilateral IMA grafting,
chronic obstructive pulmonary disease with long-term
bronchodilator therapy and obesity are important predic-
tors of mediastinitis after cardiac surgery.
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